What did @abbyg.garcia actually say?
She's been on semaglutide (she calls it "time to glue time," clearly a transcription artifact) for two months, lost 20 pounds, and claims it gave her "a natural cycle" after what's implied to be PCOS-related irregularity. She's now at 1 mg, eating whole foods, going mostly gluten-free, and promoting Belle Health with a discount code. She says she "highly, highly" recommends semaglutide for both weight loss and PCOS symptoms after just eight weeks of personal experience.
Worth noting: she's injecting on camera, switched providers at least twice, and is sharing this alongside an affiliate code. That's not automatically disqualifying, but it does mean there's a financial relationship with the provider she's recommending. Viewers deserve to know that context before they sign up using her code.
Does the science back this up?
Partially, yes. The weight loss and cycle restoration claims are plausible and supported by real research, but "two months" is not enough time to draw the conclusions she's drawing, and the mechanism is more complicated than the video implies.
On weight loss: a 2022 trial by Wilding et al. in the New England Journal of Medicine showed semaglutide 2.4 mg produced roughly 15% body weight reduction over 68 weeks. Twenty pounds in two months is at the faster end but not impossible, especially early in treatment when water weight and appetite suppression are both in play.
On PCOS and menstrual cycles: a 2023 study by Cena et al. in the Journal of Clinical Medicine found GLP-1 receptor agonists improved menstrual regularity in women with PCOS, likely through weight reduction and improved insulin sensitivity rather than any direct hormonal action. So the mechanism isn't magic. It's metabolic. That's an important distinction the video glosses over entirely.
What did they get wrong (or right)?
She gets partial credit for the weight and cycle results being clinically plausible. She also correctly identifies that she's "just watching what I eat" and focusing on whole foods, which matters. Semaglutide is not a standalone intervention. Diet quality still drives outcomes.
What she gets wrong is scope and certainty. Saying she "highly, highly" recommends semaglutide for PCOS symptoms after two months, to an audience of 74,000 people, is irresponsible framing. She hasn't had labs repeated. She doesn't know if her cycle returned because of the drug, the weight loss, the diet change, or some combination. Attributing it all to the shot is a leap.
She also mentions going "gluten free" as part of her protocol. There is no strong clinical evidence that gluten-free diets improve PCOS outcomes in women without celiac disease. A 2023 review in Nutrients found insufficient data to recommend it broadly. Pairing that with semaglutide and calling the combo a success doesn't tell you which variable is doing the work.
What should you actually know?
GLP-1 receptor agonists like semaglutide are being studied for PCOS, and the early data is genuinely interesting. But "interesting early data" and "two months of personal results" are not the same thing. PCOS involves insulin resistance, androgen excess, and ovulatory dysfunction in varying combinations. One person's cycle returning does not mean the drug will do the same for you, especially if your PCOS presentation is different.
Compounded semaglutide, which is likely what Belle Health and similar telehealth platforms dispense, is not the same as FDA-approved Wegovy or Ozempic. The FDA has warned that compounded versions vary in concentration and formulation. Assuming equivalency is a mistake. Ask your provider specifically what you're being prescribed and from which compounding pharmacy.
If you have PCOS and are considering a GLP-1 medication, talk to an endocrinologist or reproductive endocrinologist who can review your full hormone panel, not just a telehealth intake form. A discount code on TikTok is not a clinical evaluation.
The bottom line
This video is enthusiastic, visually compelling, and financially motivated. The underlying claims are not fabricated, but they are extrapolated well beyond what eight weeks of one person's experience can support. Weight loss on semaglutide is real. Menstrual cycle improvement in PCOS with GLP-1 agonists is being studied with promising early signals. But the confidence with which she says "I highly, highly recommend it" for PCOS, to tens of thousands of followers, based on two months of data, is the problem. She experienced something. That doesn't make it a prescription for you.